top of page
Scientific Presentation & Visual Identity for Galmed Pharmaceuticals
Galmed Pharmaceuticals sought a clear investor presentation to communicate the scientific rationale and therapeutic potential of a novel drug candidate. The project included the development of a visual identity for Amilo-5MER, along with the design of a structured scientific investor presentation.
This approach translated complex biological mechanisms and clinical data into a clear, persuasive narrative for investors and decision makers.
Building a visual identity for a novel therapeutic approach
A clear and distinctive visual language was developed for Amilo-5MER, translating its scientific mechanism into a credible, confident brand.
The identity system - logo, color palette and visual motifs - reflects precision, progression and therapeutic value, supporting both scientific communication and investor-facing materials.
Scientific Investor Presentation for Amilo-5MER
Translating a novel immunological mechanism into a clear visual narrative connecting biology, clinical relevance and market potential for investors and decision makers.
bottom of page